Loading
Biosnch.ai
BioSynch AI is an AI-native drug discovery company that turns early drug R&D into an engineering workflow, combining advanced machine-learning models, very large biological datasets, and an integrated wet-lab, to design and advance new medicines faster and with higher odds of success.
Funding
Every round, secondary, debt facility or acquisition involving Biosnch.ai that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—